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Abstract
Background: The health system in Iraq has undergone progressive decline since the embargo that
followed the second gulf war in 1991. The aim of this study is to see barriers to glycemic control
form the patient perspective, in a diabetic clinic in the south of Iraq.
Methods: A cross sectional study from the diabetes out-patient clinic in Al-Faiha general hospital
in Basrah, South Iraq for the period from January to December 2007. The study includes diabetic
patients whether type 1 or 2 if they have at least one year of follow up in the same clinic. Those
with A1C ≥ 7% were interviewed by special questionnaire, that was filled in by the medical staff of
the clinic. The subjects analyzed in this study were adults (≥ 18 years old) with previously diagnosed
diabetes (n = 3522). The duration of diabetes range from 1 to 30 years.
Results: Mean A1C was 8.4 ± 2 percent, with 835(23.7%) patients with A1C less than 7% and
2688(76.3%) equal to or more than 7%. Of 3522 studied patients, 46.6% were men and 51.5% were
women, with mean age of 53.78 ± 12.81 year and age range 18–97 years. Patient opinion for not
achieving good glycemic control among 2688 patients with HbA1C ≥ 7% included the following. No
drug supply from primary health care center (PHC) or drug shortage is a cause in 50.8% of cases,
while drugs and or laboratory expense were the cause in 50.2%. Thirty point seven percent of
patients said that they were unaware of diabetics complications and 20.9% think that diabetes is an
untreatable disease. Thirty percent think that non-control of their diabetes is due to migration after
the war. No electricity or erratic electricity, self-monitoring of blood glucose (SMBG) is not
available, or strips were not available or could not be used, and illiteracy as a cause was seen in
15%, 10.8% and 9.9% respectively.
Conclusion: Our patients with diabetes mellitus declared that of the causes for poor glycemic
control most of them related to the current health situation in Iraq.
Background
The health system in Iraq underwent progressive decline
since the embargo that followed the second gulf war in
1991. The war in 2003, exacerbated that by causing fur-
ther damage to the infrastructure, with lack of security that
making even drug distribution unsafe, with further deteri-
oration due to electricity problems [1-3]. This makes drug
storage even more difficult.
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Reports by the United Nations assistance mission for Iraq
indicate that the war in Iraq caused hundreds of thou-
sands of civilians have been displaced, and that military
operations in the country are limiting civilian access to
health and education services, food, electricity and water
supplies [3]. Currently, the Iraqi health system is unable
to cope with the health care needs of its population [2,4].
Attaining glycemic control (defined as a A1C concentra-
tion of less than 7.0%) is imperative for the delay or pre-
vention of diabetes related complications, which are the
real dangers of type 2 diabetes [5,6].
For each 1% reduction in the mean A1C, there was a 21%
risk reduction for any diabetes-related end point, includ-
ing myocardial infarction, stroke, amputation, and micro-
vascular complications [7].
Despite the increasing prevalence of diabetes, improved
understanding of the disease, and a variety of new medi-
cations, glycemic control does not appear to be improving
even in developed nations [8].
Most diabetic patients are likely to encounter barriers to
care that pose major challenges in adhering to self-man-
agement programmes[9]. Determining the barriers to
achieving optimal glycemic control is important in ena-
bling patients to do better in terms of improving diabetes
control and thereby reducing risk of longer-term compli-
cations[10]. The most frequently reported barriers are
time constraints, knowledge deficits, limited social sup-
port, inadequate resources, limited coping skills, poor
patient-provider relationship and low self-efficacy[11,12].
General practitioners (GPs) often assume that the best
methods to increase compliance/adherence are shocking
the patients, putting pressure on them and threatening to
refer them to hospital in a study of GPs' perspectives of
type 2 diabetes patients' adherence to treatment[13]. The
problems and barriers perceived by GPs providing diabe-
tes care in primary care in England and Wales were lack of
time/under-funding and keeping up to date in the area of
diabetes, followed by lack of space, inadequate chirop-
ody, dietetics, ophthalmology and access to secondary
care[14].
Of a population of 27 million Iraqi populations, the prev-
alence of type 2 diabetes is reaching epidemic propor-
tions, impacting an estimated 2 million people–7.43% of
the overall Iraqi population[15].
The aim of this study is to see barriers to glycemic control
form the patient perspective in a diabetic clinic in the
south of Iraq.
Methods
Participants were recruited in this cross-sectional study
from the diabetes out-patient clinic in Al-Faiha general
hospital in Basrah, Southern Iraq for the period from Jan-
uary to December 2007.
The study includes diabetic patients whether type 1 or 2 if
they had at least one year of follow up in the same clinic.
Those with A1C ≥ 7% were interviewed by special ques-
tionnaire that was filled out by the medical staff of the
clinic. Overall, 8 questions were present in the question-
naire. Patients were asked to mention the main causes of
poor glycemic control from these 8 questions, and to
choose more than one answer according to their wishes.
The answers were yes or no. These questionnaires where
suggested from the patients opinion for the cause of poor
glycemic control of the last year preceding this study.
All the patients agreed to participate in the study with
written informed consent taken. Ethical approval was
taken from the local ethical committee in Basrah directo-
rate of health.
Exclusion criteria were age less than 18 years, pregnant
women, and patients with a history of diabetes for less
than 1 year, less than one year of follow up in the clinic or
those had no value of A1C.
The subjects analyzed in this study were adults (≥ 18 years
old) with previously diagnosed diabetes (n = 3522). The
duration of diabetes ranged from 1 to 30 years.
Lifestyle modification where used for of our patients with
oral antidiabetic drugs (OAD), metformin unless there
was high serum creatinine levels ≥ 132.6 μmol/L (1.5 mg/
dl) according to guidelines [16].
Smokers were considered for any one who had smoked at
least 1 cigarette in the past 3 months.
Anthropometric measurements
Waist circumference (WC) was measured at the umbilical
level from the horizontal plane in centimeters (cm), using
a plastic anthropometric tape with the subjects standing
and breathing normally by the same physician during the
physical examination with the participant standing erect.
Standing height and weight measurements were com-
pleted with the subjects wearing lightweight clothing and
no shoes. Height was measured to the nearest cm and
weight was measured to the nearest half kilogram (kg).
Body mass index (BMI) was calculated as body weight in
kilograms divided by the squared value of body height in
meters (kg/m2). Waist to hip ratio (WHpR) and waist to
height ration (WHtR) were measured accordingly as
ratios.Conflict and Health 2008, 2:7 http://www.conflictandhealth.com/content/2/1/7
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Blood pressure was measured with a mercury sphyg-
momanometer on the right arm with the subjects in a sit-
ting position after a 5 min rest. Hypertension was defined
as systolic blood pressure ≥ 140 mmHg and/or diastolic
blood pressure ≥ 90 mmHg and/or current medication
with antihypertensive drugs.
Coronary heart disease diagnosis was based on a history
of admission to CCU with elevated cardiac biomarkers,
electrocariographic evidence of Q wave myocardial infarc-
tion or left bundle branch block, echocardiographic seg-
mental wall motion abnormalities, abnormal
angiocardiography, percutaneous coronary intervention
or coronary artery bypass surgery. Cerebrovascular disease
was diagnosed on the basis of sudden neurologic deficit
that lasted for 24 hours with or without neuroimaging
changes. Proteinuria was considered on the basis of per-
sistent frank proteinuria without RBC or WBC in urine.
All measurements of A1C were performed in a laboratory
using an ion-exchange HPLC method, whose upper refer-
ence limit was 5.8%.
Statistical analysis
Patients' characteristics were reported as percentages or
mean ± standard deviation. Statistical analysis was per-
formed using SPSS for WINDOWS (SPSS Inc., Chicago, IL,
USA). Two-sample comparisons of individual characteris-
tics were performed by Student's t-test or x2 test. Differ-
ences were considered significant at the P < 0.05 level for
all these tests.
Patients' characteristics were reported as percentages or
mean ± standard deviation.
Results
Mean A1C was 8.4 ± 2 percent, with 835 (23.7%) patients
having A1C less than 7% and 2688(76.3%) were equal to
or more than 7%. Table 1, shows basic study characteris-
tics. Of 3522 studied patients, 46.6% were men and
51.5% were women, with mean age of 53.78 ± 12.81 years
and age range 18–97 years. Smokers constituted 20.6% of
the study sample. The mean qualification (years of school
achievement) was 5.08 ± 5.67 years and 1725(49.0%)
were Illiterate. Urban dwellers constituted 60.8%. Mean
weight, waist, and BMI were 76.04 ± 16.94 kg, 98.4 ± 12.9
cm and 27.6 ± 5.6 respectively. The WHpR and WHtR
were 0.94 ± .07 and 0.59 ± .08 respectively. Type 1 diabe-
tes mellitus constituted for 3.6% and the others were type
2 diabetes mellitus. Insulin with or without OAD was
used in 20.8%. Hypertensive constituted 32.1% of the
study sample. Coronary heart disease, cerebrovascular dis-
ease and proteinuria were seen in 7.2%, 4.3% and 5.3%
respectively.
Table 2, shows patient opinion for not achieving good gly-
cemic control among the 2688 patients with A1C ≥ 7%.
No drug supply from primary health care center (PHC) or
drug shortage is a cause in 50.8%, while drugs and or lab-
oratory expense were the cause in 50.2%. Thirty point
seven percent of patients said that they were unaware of
diabetic complications and 20.9% thought that diabetes
is an untreatable disease. Thirty percent think that non-
Table 1: Baseline study characteristics (n = 3522, aged 18–97 years).
Variables HbA1C < 7% n = 835(%) HbA1C ≥ 7 n = 2688 (%) Total No (%) P value
Gender Men 383 (22.8) 1299 (77.2) 1676(47.6) 0.282
Women 442 (24.3) 1374 (75.7) 1816 (51.5)
Age 55.14 ± 12.96 53.35 ± 12.73 53.78 ± 12.81 0.622
Smoker 141 (19.4) 585 (80.6) 726(20.6) 0.002
Qualification 5.31 ± 5.80 5.01 ± 5.63 5.08 ± 5.67 0.401
Address Urban 518 (24.2) 1624 (75.8) 2142(60.8) 0.408
Rural 317 (23.0) 1063 (77.0) 1380(39.2)
Weight -kg-(mean ± SD) 76.84 ± 16.32 75.79 ± 17.12 76.04 ± 16.94 0.122
Waist -cm-(mean ± SD) 98.96 ± 12.4 98.3 ± 13.0 98.4 ± 12.9 0.371
BMI 28.09 ± 5.55 27.53 ± 5.62 27.6 ± 5.6 0.988
Waist-hip ratio (mean ± SD) 0.94 ± 0.06 0.94 ± 0.07 0.94 ± .07 0.030
Waist-to-height ratio (mean ± SD) 0.59 ± 0.07 0.59 ± .08 0.59 ± .08 0.903
Type of diabetes Type 1 diabetes 11 (8.7) 116 (91.3) 127(3.6) < 0.0001
Type 2 diabetes 824 (24.3) 2571(75.7) 3395(96.4)
Therapy Oral * 744 (26.7) 2044 (73.3) 2788 (79.2) < 0.0001
Insulin ± oral 91 (12.4) 643 (87.6) 734(20.8) < 0.0001
Hypertension 277 (24.5) 855 (75.5) 1132(32.1) 0.471
Coronary heart disease 55 (21.7) 198 (78.3) 253 (7.2) 0.490
Cerebrovascular disease 44 (29.3) 106 (70.7) 150(4.3) 0.116
Proteinuria 48 (25.7) 139 (74.3) 187(5.3) 0.536
* Oral including metformin was used for all except in few with high creatinine or type 1 diabetes.Conflict and Health 2008, 2:7 http://www.conflictandhealth.com/content/2/1/7
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control of their diabetes is due to migration after the war.
No electricity or erratic electricity, self-monitoring of
blood glucose (SMBG) is not available, or no strips were
available or could not be used, and illiteracy as a cause
was seen in 15%, 10.8% and 9.9% respectively.
Discussion
Our diabetic patients are far from achieving glycemic goal
since their mean A1C% was 8.4 ± 2, and only 23.7%
achieve target glycemic control according to guide-
lines[5,6]. From the National Health and Nutrition Exam-
ination Survey, < 50% of patients with self reported
diabetes were at target A1C[17].
Insulin was under used by our patients, only used in
20.8%. In United Kingdom Prospective Diabetes Study
over 6 years, ~53% of patients will require addition of
insulin therapy to achieve target HbA1C[18].
In Iraq, diabetic patients received their medications
including insulin from the PHC that distributed all over,
but after the war in 2003, there was catastrophic shortage
of drug supply [1]. That's why most patients blame the
PHC as a cause of uncontrolled of diabetes. So they buy it
from the market, in that case its expensive. Furthermore,
people do not always trust governmental hospitals in
investigations and they rely on private laboratories which
are expensive and that why 50.2% of them blame the
expense.
Unawareness of diabetic's complications is a problem in
30.7% and 20.9% thought diabetes is an untreatable dis-
ease. Not understanding the nature and consequences of
diabetes, as well as a lack of family support, correlated
with poor adherence in adults with diabetes[19]. In diabe-
tes care, patients' beliefs about the nature of their illness
influence their willingness to adhere to therapy[20].
Unfortunately, there are usually no immediate physical
benefits to the treatment of diabetes. Patients who take
their diabetes seriously are more likely to adhere to treat-
ment [21]. We have noticed that again as in previous
study in Basrah were more than 50% of our patients
stopped metformin after a while and more than 80% of
those who stopped it, did that with no medical advice to
stop it [22].
Migration was blamed in 30% of our study sample. There
is more than one type of migration in Basrah after the war,
One type is migration from other governorates in Iraq to
Basrah and another one is migration within the city. The
3rd type is out side Iraq or to other parts of the country,
and we have no data on those because they left.
Needle phobia was a problem in 13.2%. This was prob-
lem among 34.7% of 1,267 diabetic patients, in Califor-
nia [23].
Erratic electricity supply no availability of SMBG with illit-
eracy are problem sizable percents of our study. All guide-
lines for diabetes management–support the integral role
of SMBG in overall treatment programs [5,6].
Conclusion
Our patients with diabetes mellitus declared that of the
causes for poor glycemic control most of them related to
the current health situation in Iraq.
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